Arix IPO raises £100M for new biotech investments; Santhera sets up shop in Massachusetts
• As expected, the UK’s Arix Biosciences has raised £100 million in its IPO, which will now fuel a new round of investments in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
